Paper17657488
Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.
Karagiannis SN and 12 others. Cancer Immunol Immunother, 2008. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Papers, record 17657488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17657488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody-Dependent Cell Cytotoxicity | Major topic |
| Immunotherapy | Major topic |
| Monocytes | Major topic |
| Ovarian Neoplasms | Major topic |
| Phagocytosis | Major topic |
| Receptors, IgE | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Female | |
| Flow Cytometry | |
| Fluorescent Antibody Technique | |
| Humans | |
| Mice | |
| Mice, Nude |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0200486 | Medical Research Council | United Kingdom | PubMed | |
| G0501974 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2972386 | Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. | Cell | 1988 | https://conductscience.org/library/papers/2972386 | PubMed |
| 2 | 1717147 | Folate-binding protein is a marker for ovarian cancer. | Cancer Res | 1991 | https://conductscience.org/library/papers/1717147 | PubMed |
| 3 | 8634249 | Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. | Biochemistry | 1996 | https://conductscience.org/library/papers/8634249 | PubMed |
| 4 | 10960668 | Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway. | Immunopharmacology | 2000 | https://conductscience.org/library/papers/10960668 | PubMed |
| 5 | 1717839 | Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with Fc epsilon RII and Fc epsilon RI. | Mol Immunol | 1991 | https://conductscience.org/library/papers/1717839 | PubMed |
| 6 | 8428622 | Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1. | FEBS Lett | 1993 | https://conductscience.org/library/papers/8428622 | PubMed |
| 7 | 9799353 | Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration. | Eur J Nucl Med | 1998 | https://conductscience.org/library/papers/9799353 | PubMed |
| 8 | 2713487 | Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. | Blood | 1989 | https://conductscience.org/library/papers/2713487 | PubMed |
| 9 | 1531998 | Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. | J Immunol | 1992 | https://conductscience.org/library/papers/1531998 | PubMed |
| 10 | 10556807 | Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. | Eur J Immunol | 1999 | https://conductscience.org/library/papers/10556807 | PubMed |
| 11 | 7947461 | Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions. | Int Immunol | 1994 | https://conductscience.org/library/papers/7947461 | PubMed |
| 12 | 1401914 | Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. | J Immunol | 1992 | https://conductscience.org/library/papers/1401914 | PubMed |
| 13 | 17531261 | Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis. | J Immunol Methods | 2007 | https://conductscience.org/library/papers/17531261 | PubMed |
| 14 | 16617160 | Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16617160 | PubMed |
| 15 | 16622479 | Potent antibody therapeutics by design. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16622479 | PubMed |
| 16 | 10742152 | Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. | Nat Med | 2000 | https://conductscience.org/library/papers/10742152 | PubMed |
| 17 | 8674126 | The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. | Cell | 1996 | https://conductscience.org/library/papers/8674126 | PubMed |
| 18 | 12818520 | Renaissance of cancer therapeutic antibodies. | Drug Discov Today | 2003 | https://conductscience.org/library/papers/12818520 | PubMed |
| 19 | 2425938 | Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. | Cancer Res | 1986 | https://conductscience.org/library/papers/2425938 | PubMed |
| 20 | 9933083 | Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor. | Eur J Immunol | 1999 | https://conductscience.org/library/papers/9933083 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42694955 | Targeting Folate Receptors for the Detection and Selective Treatment of Cancer: Advanced Precision Oncology in Practice. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42694955 | PubMed |
| 41672926 | AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes. | Clin Exp Allergy | 2026 | https://conductscience.org/library/papers/41672926 | PubMed |
| 41567205 | The role of immunoglobulin E in non-atopic disorders. | Front Immunol | 2025 | https://conductscience.org/library/papers/41567205 | PubMed |
| 40045156 | Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age. | MAbs | 2025 | https://conductscience.org/library/papers/40045156 | PubMed |
| 39833133 | Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production. | MAbs | 2025 | https://conductscience.org/library/papers/39833133 | PubMed |
| 39273499 | Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273499 | PubMed |
| 37491373 | Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. | Nat Commun | 2023 | https://conductscience.org/library/papers/37491373 | PubMed |
| 37370828 | Allergic Diseases and Risk of Malignancy of Gastrointestinal Cancers. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37370828 | PubMed |
| 37239049 | The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239049 | PubMed |
| 36197112 | B cells defined by immunoglobulin isotypes. | Clin Exp Immunol | 2022 | https://conductscience.org/library/papers/36197112 | PubMed |
| 34513315 | In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/34513315 | PubMed |
| 34503270 | Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503270 | PubMed |
| 33081206 | IgE Antibodies against Cancer: Efficacy and Safety. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/33081206 | PubMed |
| 31544825 | IgE Antibodies: From Structure to Function and Clinical Translation. | Antibodies (Basel) | 2019 | https://conductscience.org/library/papers/31544825 | PubMed |
| 31388397 | AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice. | World Allergy Organ J | 2019 | https://conductscience.org/library/papers/31388397 | PubMed |
| 31167464 | Mast Cells and Natural Killer Cells-A Potentially Critical Interaction. | Viruses | 2019 | https://conductscience.org/library/papers/31167464 | PubMed |
| 30956175 | IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states. | EBioMedicine | 2019 | https://conductscience.org/library/papers/30956175 | PubMed |
| 29686678 | Immunoglobulin E-Mediated Autoimmunity. | Front Immunol | 2018 | https://conductscience.org/library/papers/29686678 | PubMed |
| 29654623 | An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE. | Allergy | 2018 | https://conductscience.org/library/papers/29654623 | PubMed |
| 29593727 | Effect of VH-VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding. | Front Immunol | 2018 | https://conductscience.org/library/papers/29593727 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FCER1A | 2205 | PubTator's text mining | https://conductscience.org/library/genes/2205 | NCBI Gene |
| FCER2 | 2208 | PubTator's text mining | https://conductscience.org/library/genes/2208 | NCBI Gene |
| FOLR1 | 2348 | PubTator's text mining | https://conductscience.org/library/genes/2348 | NCBI Gene |
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17657488
GET https://conductscience.org/api/papers/v1/17657488/references?page=2